Full Product Details
Author: M. O'Neill (Eolas Biosciences Limited) ,
M. M. Hopkins (University of Sussex, UK)
Publisher: Elsevier Science & Technology
Imprint: Woodhead Publishing Ltd
Volume: No. 9
Dimensions:
Width: 15.60cm
, Height: 2.40cm
, Length: 23.40cm
Weight: 0.780kg
ISBN: 9781907568145
ISBN 10: 190756814
Pages: 414
Publication Date: 02 May 2012
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: Out of stock
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.
Author Information
Dr Michael O'Neill has had a career of more than 20 years working in neuroscience research in the pharmaceutical industry, working for Merck, Laboratorios Almirall and Eli Lilly. Michael's career has given him an expert knowledge of neuroscience balanced with a strong grasp of strategic principles drug discovery and development. Michael has authored over 80 papers, book chapters, patents and abstracts. He has presented his work at major international scientific conferences. He has held an adjunct appointment and has supervised PhD students at various leading universities. Michael is an accomplished research leader with extensive program and portfolio management experience. He has lead specialist and multidisciplinary teams in the UK, Europe and in the US. As a consultant Michael has helped companies of all sizes from university start-ups to Fortune 500 companies. This book is the distillation of all that experience. Michael Hopkins is a biologist is currently a Research Fellow at Science Policy research Unit, University of Sussex, and a Visiting Research Fellow at Cass Business School (London). He specialises in the study of innovation systems related to innovations in healthcare, spanning public and private sectors, products (e.g. drugs) and services (e.g. diagnostic testing). He has published widely in natural science and social science fields on the role of intellectual property, regulation and finance in innovation (including in Nature, Nature Biotechnology and Research Policy - the top journals in their respective fields). From 2004-2006 Michael was a Research Fellow of the Economic & Social Research Council and Medical Research Council. Additionally he has worked on a wide range of research projects funded by the European Commission's framework programmes, and Joint Research Centre, the UK's Engineering and Physical Sciences Research Council, the National Endowment for Science Technology and the Arts, the UK's Department of Trade and Industry, Human Genetics Commission and Strategic Advisory Board for Intellectual Property.
